BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/28/2020 3:42:19 AM | Browse: 1187 | Download: 2488
 |
Received |
|
2020-01-13 08:44 |
|
Peer-Review Started |
|
2020-01-13 08:44 |
|
First Decision by Editorial Office Director |
|
2020-01-16 20:04 |
|
Return for Revision |
|
2020-01-16 20:04 |
|
Revised |
|
2020-01-20 15:22 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-02-20 17:04 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-02-21 05:55 |
|
Articles in Press |
|
2020-02-21 05:55 |
|
Edit the Manuscript by Language Editor |
|
2020-02-24 02:12 |
|
Typeset the Manuscript |
|
2020-02-26 08:21 |
|
Publish the Manuscript Online |
|
2020-02-28 03:42 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Neoadjuvant chemotherapy vs upfront surgery for gastric signet ring cell carcinoma: A retrospective, propensity score-matched study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yang Li, Fu-Hai Ma, Li-Yan Xue and Yan-Tao Tian |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81772642 |
| Capital’s Funds for Health Improvement and Research |
CFH 2018-2-4022 |
|
| Corresponding Author |
Yan-Tao Tian, MD, Professor, Surgeon, Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing 100021, China. tyt67@163.com |
| Key Words |
Stomach neoplasms; Neoadjuvant therapy; Retrospective studies; Carcinoma; Signet ring cell; Outcome assessment |
| Core Tip |
Gastric cancer is the fifth most frequently diagnosed cancer and the second leading cause of cancer-related death globally. Despite a decrease in the overall incidence of gastric cancer in recent decades, the incidence of the subgroup of patients with signet-ring cell carcinoma is growing. This study provides evidence that neoadjuvant chemotherapy does not provide any survival advantage in gastric signet-ring cell carcinoma. For resectable gastric signet-ring cell carcinoma, surgery should be the primary therapy. |
| Publish Date |
2020-02-28 03:42 |
| Citation |
Li Y, Ma FH, Xue LY, Tian YT. Neoadjuvant chemotherapy vs upfront surgery for gastric signet ring cell carcinoma: A retrospective, propensity score-matched study. World J Gastroenterol 2020; 26(8): 818-827 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i8/818.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i8.818 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
